PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to shield kids from 24 pneumococcal strains
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests a new vaccine (PCV24) designed to protect children from 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. About 230 healthy children aged 2 months to 17 years will receive the vaccine or a placebo to …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:05 UTC
-
New vaccine aims to shield adults from 24 types of pneumococcal disease
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine designed to protect adults aged 18 and older against 24 types of pneumococcal bacteria, which can cause pneumonia and other infections. Around 992 participants will receive the vaccine to check its safety and how well it triggers the immune system. …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:03 UTC